Loading…
InMode Ltd. is projected to rise to $17.45 by 2027, a +26% move from its current price of $13.81. INMD is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $13.63 | $13.81 | $13.99 | +0.02% |
| May 30 | $13.56 | $13.81 | $14.07 | +0.03% |
| May 31 | $13.51 | $13.82 | $14.13 | +0.05% |
| Jun 1 | $13.47 | $13.82 | $14.18 | +0.07% |
| Jun 2 | $13.43 | $13.82 | $14.23 | +0.08% |
| Jun 3 | $13.39 | $13.82 | $14.27 | +0.10% |
| Jun 4 | $13.36 | $13.83 | $14.31 | +0.12% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $13.36 | $13.83 | $14.31 | +0.12% |
| Week 2 | $13.19 | $13.84 | $14.53 | +0.23% |
| Week 3 | $13.06 | $13.86 | $14.71 | +0.35% |
| Week 4 | $12.96 | $13.87 | $14.86 | +0.47% |
| Week 5 | $12.87 | $13.89 | $15.00 | +0.59% |
| Week 6 | $12.79 | $13.91 | $15.13 | +0.70% |
| Week 7 | $12.72 | $13.92 | $15.25 | +0.82% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally. It offers minimally invasive aesthetic medical products for liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures.
The company also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions. In addition, it offers hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation.
The company sells and markets its products in the United States, Canada, the United Kingdom, Ireland, Spain, Portugal, France, Belgium, Luxemburg, Italy, Germany, Austria, Japan, Australia, and India through distributors. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd.
in November 2017. The company was incorporated in 2008 and is headquartered in Yokne'am, Israel.
InMode Ltd. (INMD) is a healthcare company with a current price of $13.74 and a market capitalization of $835.51M. It is ranked 2661 by market cap. The stock sits in a landscape where near-term forecasts show varying upside potential, with longer-term averages continuing to rise across multiple years.
As of the latest data, the forecasted averages indicate a path of growth beyond the near term, with the 2026 average price at $13.74, rising to $23.13 by 2030, and extending to $101.62 by 2050. These trajectories accompany bullish sentiment in most future years, with max forecasts reaching up to $166.29 by 2050.
A major floor 7.6% below — a decisive break under it would weaken the trend.
Price is testing support right now (1.6% away) — a key level to hold.
The nearest ceiling, 6.1% above — a clean break opens room to run.
A major ceiling 20.3% above — clearing it would confirm fresh momentum.
Key INMD support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of INMD market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $13.84 | Sell | $13.84 | Sell |
| MA 10 | $13.93 | Sell | $13.89 | Sell |
| MA 20 | $13.99 | Sell | $13.96 | Sell |
| MA 50 | $13.95 | Sell | $14.01 | Sell |
| MA 100 | $14.18 | Sell | $14.14 | Sell |
| MA 200 | $14.45 | Sell | $14.52 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 45.49 | Neutral |
| Stoch RSI (14) | 24.38 | Neutral |
| CCI (20) | -66.70 | Neutral |
| Williams %R (14) | -80.56 | Info |
| MACD (12,26,9) | -0.03 | Sell |
| ROC (12) | -1.07 | Sell |
| Bollinger %B (20,2) | 0.30 | Neutral |
| Stochastic %K (14) | 19.44 | Buy |
| TRIX (15) | -0.03 | Sell |
| Awesome (5,34) | -0.25 | Sell |
| Ultimate (7,14,28) | 47.46 | Neutral |
| Momentum (10) | -0.02 | Sell |
| Aroon Osc (25) | -44.00 | Sell |
| Hull MA (9) | 13.74 | Buy |
| ADX (14) | 9.08 | Neutral |
| ATR (14) | 0.14 | Info |
Sentiment in the 30-day picture is BEARISH. RSI14 is 40. The stock trades near a SMA50 of $13.94 and a SMA200 of $14.45, with a support level at $13.59 and resistance at $14.65.
The 30-day price range runs from a low of $12.55 to a high of $15.04, reflecting a短-term trading band around the current price.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $12.76 | $13.81 | $18.91 | 0% | Neutral | |
| $14.26 | $17.45 | $22.36 | +26% | Bullish | |
| $16.28 | $20.29 | $26.68 | +47% | Bullish | |
| $18.52 | $23.43 | $31.45 | +70% | Bullish | |
| $18.20 | $23.33 | $31.87 | +69% | Bullish | |
| $18.91 | $24.54 | $34.04 | +78% | Bullish | |
| $20.64 | $27.08 | $38.09 | +96% | Bullish | |
| $21.88 | $29.01 | $41.33 | +110% | Bullish | |
| $26.44 | $35.40 | $51.03 | +156% | Bullish | |
| $28.51 | $38.54 | $56.17 | +179% | Bullish | |
| $37.32 | $52.60 | $80.32 | +281% | Bullish | |
| $68.23 | $103.12 | $168.73 | +647% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $12.76 | $13.81 | $16.15 | +0.00% |
| June 2026 | $11.74 | $13.69 | $16.28 | -0.86% |
| July 2026 | $11.95 | $14.02 | $16.83 | +2.42% |
| August 2026 | $12.44 | $14.66 | $17.73 | +4.57% |
| September 2026 | $12.50 | $14.79 | $17.99 | +0.86% |
| October 2026 | $12.43 | $14.75 | $18.04 | -0.25% |
| November 2026 | $12.71 | $15.13 | $18.59 | +2.55% |
| December 2026 | $12.84 | $15.32 | $18.91 | +1.30% |
Click any year to see its month-by-month INMD forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
InMode Ltd.'s 2026 outlook centres on $13.81, within a $12.76 to $18.91 range. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2027, INMD could reach as high as $22.36, with a base case around $17.45 and support toward $14.26 — roughly +26% from $13.81. Momentum favours further upside here.
Expect INMD to range from $16.28 to $26.68 through 2028. The $20.29 average target implies a +47% move from current prices. That is up +16% on the projected 2027 average. Buyers look set to stay in control over this stretch.
The INMD price prediction for 2029 points to an average of $23.43 (low $18.52, high $31.45) — a potential gain of +70% on today's $13.81. Momentum favours further upside here.
In 2030, INMD is projected to trade between $18.20 and $31.87, averaging $23.33 — a potential gain of +69% from today's $13.81. That is 0% versus the projected 2029 average. Buyers look set to stay in control over this stretch.
InMode Ltd.'s 2031 outlook centres on $24.54, within a $18.91 to $34.04 range. That is up +5% on the projected 2030 average. That marks a +78% change versus current levels. Momentum favours further upside here.
By 2032, INMD could reach as high as $38.09, with a base case around $27.08 and support toward $20.64 — roughly +96% from $13.81. Buyers look set to stay in control over this stretch.
Expect INMD to range from $21.88 to $41.33 through 2033. The $29.01 average target implies a +110% move from current prices. That is up +7% on the projected 2032 average. Momentum favours further upside here.
The INMD price prediction for 2034 points to an average of $35.40 (low $26.44, high $51.03) — a potential gain of +156% on today's $13.81. Buyers look set to stay in control over this stretch.
In 2035, INMD is projected to trade between $28.51 and $56.17, averaging $38.54 — a potential gain of +179% from today's $13.81. That is up +9% on the projected 2034 average. Momentum favours further upside here.
InMode Ltd.'s 2040 outlook centres on $52.60, within a $37.32 to $80.32 range. That is up +37% on the projected 2035 average. That marks a +281% change versus current levels. Buyers look set to stay in control over this stretch.
By 2050, INMD could reach as high as $168.73, with a base case around $103.12 and support toward $68.23 — roughly +647% from $13.81. Momentum favours further upside here.
Investing $1,000 in INMD today (≈ 72.411296 INMD) could be worth
$7,467.16
+$6,467.16 (+647%) by 2050 · US Dollar
Based on the average projected INMD price of $103.12 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in INMDwould be worth at today's price.
$1,000 invested in INMD on May 27, 2025 (≈ 68.775791 INMD) would be worth
$949.79
-$50.21 (-5.0%) today · 0.95× · US Dollar
Based on a INMD entry price of $14.54 vs. today's $13.81.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $14.02 | $985.02 | -1.5% |
| 1 month ago | $14.31 | $965.06 | -3.5% |
| 3 months ago | $14.05 | $982.92 | -1.7% |
| 6 months ago | $14.25 | $969.12 | -3.1% |
| 1 year ago | $14.54 | $949.79 | -5.0% |
| All time (5.0y) ago | $42.45 | $325.32 | -67.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our INMD forecast.
Our base-case forecast reaches $28.00 around 2033.
Implied market cap at $28.00: $1.7B
The multi-year forecast shows a bullish trajectory with steady gains across the evaluation horizon. In 2027 the average price is forecast at $17.36 (ROI 26.4) and the momentum continues with 2028 at $20.29 (ROI 47.6) and 2029 at $23.26 (ROI 69.3). By 2030 the average is $23.13 (ROI 68.3).
Looking further out, 2031 is projected at $24.44 (ROI 77.9), 2032 at $26.89 (ROI 95.7), and 2033 at $28.81 (ROI 109.7). The forecast accelerates later in the period, with 2034 averaging $35.23 (ROI 156.4) and 2035 at $38.18 (ROI 177.9). By 2040, the average price is forecast at $52.53 (ROI 282.3), and by 2050 it is $101.62 (ROI 639.6).
These are estimates and not guarantees; actual outcomes depend on market conditions and other factors.
Tap a question to reveal the answer.
The 2030 average price is $23.13 with a forecasted ROI of 68.3. The 2030 min and max are $18.04 and $31.60 respectively.
Forecasts show bullish sentiment from 2027 onward, with 2027 avg $17.36 (ROI 26.4) and 2030 avg $23.13 (ROI 68.3), rising to 2050 avg $101.62 (ROI 639.6). These are estimates, not guarantees.
Yes. The forecasted max prices reach $50.80 by 2034 and $80.22 by 2040, with a further high of $166.29 by 2050.
The 30-day range is $12.55 to $15.04.
Current price is $13.74 and market cap is $835.51M.
InMode Ltd. Community Discussion
0Share your InMode Ltd. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.